Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Breast Cancer Research and Treatment|August 6, 2002
Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serumStefania Forti, Matthew J Scanlan, Annamaria Invernizzi, et al.Lung Cancer (Amsterdam, Netherlands)|September 27, 2003
Expression of cancer/testis (CT) antigens in lung cancerKouhei Tajima, Yuichi Obata, Hiromi Tamaki, et al.Cancer Immunity|October 19, 2004
SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancerJonathan Tammela, Achim A Jungbluth, Feng Qian, et al.Cancer Immunity|November 18, 2004
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancerSang-Yull Lee, Barbara Williamson, Otavia L Caballero, et al.International Journal of Cancer|March 29, 2002
Identification of cancer/testis genes by database mining and mRNA expression analysisMatthew J Scanlan, Claudia M Gordon, Barbara Williamson, et al.Cancer Research|July 19, 2002
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targetsMatthew J Scanlan, Sydney Welt, Claudia M Gordon, et al.International Journal of Cancer|March 18, 2004
Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune responseFrancesca Di Modugno, Giovanna Bronzi, Matthew J Scanlan, et al.Proceedings of the National Academy of Sciences of the United States of America|May 21, 2005
Identification of cancer/testis-antigen genes by massively parallel signature sequencingYao-Tseng Chen, Matthew J Scanlan, Charis A Venditti, et al.Cancer Research|October 3, 2003
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancerKunle Odunsi, Achim A Jungbluth, Elisabeth Stockert, et al.Cancer Immunity|January 13, 2006
Glycoprotein A34, a novel target for antibody-based cancer immunotherapyMatthew J Scanlan, Gerd Ritter, Beatrice W T Yin, et al.Pageof 3